Intravital imaging - Dynamic insights into natural killer T cell biology

Frontiers in Immunology

Volumn 6, Issue MAY, 2015, Pages

  Liew, Pei Xiong ^a   Kubes, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Host pathogen interactions; Innate immunity; Intravital imaging; Natural killer T cells; Sterile inflammation

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1 ANTIGEN; CD1D ANTIGEN; CHEMOKINE RECEPTOR CXCR3; COLONY STIMULATING FACTOR; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; BORRELIA BURGDORFERI; CELL FUNCTION; CYTOKINE RELEASE; CYTOLOGY; DEFENSE MECHANISM; FLUORESCENCE MICROSCOPY; HOST PATHOGEN INTERACTION; HUMAN; IMAGING; INNATE IMMUNITY; NATURAL KILLER T CELL; NONHUMAN; PNEUMOCOCCAL INFECTION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; REVIEW; SPHINGOMONAS; T LYMPHOCYTE ACTIVATION; TH2 CELL; TISSUE INJURY;

EID: 84934282968     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00240     Document Type: Review

References (110)

1. Wagner R. Erlauterungstaflen zur Physiologie und Entwicklungsgeschichte. Leipzig: Leopold Voss (1839).
2. Wagner DD, Frenette PS. The vessel wall and its interactions. Blood (2008) 111(11):5271-81. doi: 10.1182/blood-2008-01-078204
3. Petri B, Phillipson M, Kubes P. The physiology of leukocyte recruitment: an in vivo perspective. J Immunol (2008) 180(10):6439-46. doi:10.4049/jimmunol.180.10.6439
4. Mempel TR, Scimone ML, Mora JR, von Andrian UH. In vivo imaging of leukocyte trafficking in blood vessels and tissues. Curr Opin Immunol (2004) 16(4):406-17. doi:10.1016/j.coi.2004.05.018
5. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods (2010) 7(8):603-14. doi:10.1038/nmeth.1483
6. Pittet MJ, Weissleder R. Intravital imaging. Cell (2011) 147(5):983-91. doi:10.1016/j.cell.2011.11.004
7. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science (2010) 330(6002):362-6. doi:10.1126/science.1195491
8. Wong CHY, Jenne CN, Lee WY, Leger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science (2011) 334(6052):101-5. doi:10.1126/science.1210301
9. Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, van Rooijen N, et al. An intravascular immune response to Borrelia burgdorferi involves kupffer cells and iNKT cells. Nat Immunol (2010) 11(4):295-302. doi:10.1038/ni.1855
10. Ishii T, Ishii M. Intravital two-photon imaging: a versatile tool for dissecting the immune system. Ann Rheum Dis (2011) 70(Suppl 1):i113-5. doi:10.1136/ard.2010.138156
11. Helmchen F, Denk W. Deep tissue two-photon microscopy. Nat Methods (2005) 2(12):932-40. doi:10.1038/nmeth818
12. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol (2004) 4(3):231-7. doi:10.1038/nri1309
13. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol (1997) 15:535-62. doi:10.1146/annurev.immunol.15.1.535
14. Carlyle JR, Mesci A, Ljutic B, Belanger S, Tai LH, Rousselle E, et al. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol (2006) 176(12):7511-24. doi:10.4049/jimmunol.176.12.7511
15. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol (2013) 13(2):101-17. doi:10.1038/nri3369
16. Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol (2000) 164(4):2009-15. doi:10.4049/jimmunol.164.4.2009
17. Porcelli S, Morita CT, Brenner MB. CD1b restricts the response of human CD4-8-T lymphocytes to a microbial antigen. Nature (1992) 360(6404):593-7. doi:10.1038/360593a0
18. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature (1994) 372(6507):691-4. doi:10.1038/372691a0
19. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol (2004) 22:817-90. doi:10.1146/annurev.immunol.22.012703.104608
20. Cohen NR, Garg S, Brenner MB. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol (2009) 102:1-94. doi:10.1016/S0065-2776(09)01201-2
21. Barral DC, Brenner MB. CD1 antigen presentation: how it works. Nat Rev Immunol (2007) 7(12):929-41. doi:10.1038/nri2191
22. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR. CD1 recognition by mouse NK1+ T lymphocytes. Science (1995) 268(5212):863-5. doi:10.1126/science.7538697
23. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J Exp Med (1995) 182(6):2091-6. doi:10.1084/jem.182.6.2091
24. Exley M, Garcia J, Balk SP, Porcelli S. Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8-T cells. J Exp Med (1997) 186(1):109-20. doi:10.1084/jem.186.1.109
25. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 278(5343):1626-9. doi:10.1126/science.278.5343.1626
26. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med (2000) 191(11):1895-903. doi:10.1084/jem.191.11.1895
27. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med (2000) 192(5):741-53. doi:10.1084/jem.192.5.741
28. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells. J Exp Med (1994) 180(3):1171-6. doi:10.1084/jem.180.3.1171
29. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, et al. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med (1998) 188(8):1521-8. doi:10.1084/jem.188.8.1521
30. Liu Y, Goff RD, Zhou D, Mattner J, Sullivan BA, Khurana A, et al. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J Immunol Methods (2006) 312(1-2):34-9. doi:10.1016/j.jim.2006.02.009
31. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI. Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol (2012) 12(12):845-57. doi:10.1038/nri3328
32. Lawson V. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells. Immunology (2012) 137(1):20-7. doi:10.1111/j.1365-2567.2012.03612.x
33. Reilly EC, Wands JR, Brossay L. Cytokine dependent and independent iNKT cell activation. Cytokine (2010) 51(3):227-31. doi:10.1016/j.cyto.2010.04.016
34. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol (2011) 11(2):131-42. doi:10.1038/nri2904
35. Berzins SP, Ritchie DS. Natural killer T cells: drivers or passengers in preventing human disease? Nat Rev Immunol (2014) 14(9):640-6. doi:10.1038/nri3725
36. Behar SM, Podrebarac TA, Roy CJ, Wang CR, Brenner MB. Diverse TCRs recognize murine CD1. J Immunol (1999) 162(1):161-7.
37. Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D. Cd1-restricted Cd4(+) T-cells in major histocompatibility complex class Ii-deficient mice. J Exp Med (1995) 182(4):993-1004. doi:10.1084/jem.182.4.993
38. Park SH, Roark JH, Bendelac A. Tissue-specific recognition of mouse CD1 molecules. J Immunol (1998) 160(7):3128-34.
39. Arrenberg P, Halder R, Dai Y, Maricic I, Kumar V. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid. Proc Natl Acad Sci U S A (2010) 107(24):10984-9. doi:10.1073/pnas.1000576107
40. Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med (2001) 193(8):893-904. doi:10.1084/jem.193.8.893
41. Blomqvist M, Rhost S, Teneberg S, Lofbom L, Osterbye T, Brigl M, et al. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur J Immunol (2009) 39(7):1726-35. doi:10.1002/eji.200839001
42. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med (2004) 199(7):947-57. doi:10.1084/jem.20031389
43. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol (2005) 23:877-900. doi:10.1146/annurev.immunol.23.021704.115742
44. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol (2007) 25:297-336. doi:10.1146/annurev.immunol.25.022106.141711
45. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med (2003) 198(7):1069-76. doi:10.1084/jem.20030630
46. Van Kaer L, Parekh VV, Wu L. Invariant natural killer T cells as sensors and managers of inflammation. Trends Immunol (2013) 34(2):50-8. doi:10.1016/j.it.2012.08.009
47. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol (2003) 4(12):1230-7. doi:10.1038/ni1002
48. Mattner J, DeBord KL, Ismail N, Goff RD, Cantu C, Zhou DP, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 434(7032):525-9. doi:10.1038/nature03408
49. Kinjo Y, Wu D, Kim GS, Xing GW, Poles MA, Ho DD, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature (2005) 434(7032):520-5. doi:10.1038/nature03407
50. Ambrosino E, Berzofsky JA, Terabe M. Regulation of tumor immunity: the role of NKT cells. Expert Opin Biol Ther (2008) 8(6):725-34. doi:10.1517/14712598.8.6.725
51. Metelitsa LS. Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin Immunol (2011) 140(2):119-29. doi:10.1016/j.clim.2010.10.005
52. Balato A, Unutmaz D, Gaspari AA. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol (2009) 129(7):1628-42. doi:10.1038/jid.2009.30
53. Van Kaer L. Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol Cell Biol (2004) 82(3):315-22. doi:10.1111/j.0818-9641.2004.01252.x
54. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ, et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol (2007) 178(5):2827-34. doi:10.4049/jimmunol.178.5.2827
55. Sakuishi K, Oki S, Araki M, Porcelli SA, Miyake S, Yamamura T. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol (2007) 179(6):3452-62. doi:10.4049/jimmunol.179.6.3452
56. Yu KO, Im JS, Molano A, Dutronc Y, Illarionov PA, Forestier C, et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci U S A (2005) 102(9):3383-8. doi:10.1073/pnas.0407488102
57. Sullivan BA, Nagarajan NA, Wingender G, Wang J, Scott I, Tsuji M, et al. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J Immunol (2010) 184(1):141-53. doi:10.4049/jimmunol.0902880
58. Im JS, Arora P, Bricard G, Molano A, Venkataswamy MM, Baine I, et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity (2009) 30(6):888-98. doi:10.1016/j.immuni.2009.03.022
59. Bai L, Constantinides MG, Thomas SY, Reboulet R, Meng F, Koentgen F, et al. Distinct APCs explain the cytokine bias of alpha-galactosylceramide variants in vivo. J Immunol (2012) 188(7):3053-61. doi:10.4049/jimmunol.1102414
60. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol (2002) 3(9):867-74. doi:10.1038/ni827
61. Buechel HM, Stradner MH, D'Cruz LM. Stages versus subsets: invariant natural killer T cell lineage differentiation. Cytokine (2015) 72(2):204-9. doi:10.1016/j.cyto.2014.12.005
62. Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, et al. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol (2010) 11(4):303-12. doi:10.1038/ni.1853
63. Abe T, Fujimori T. Reporter mouse lines for fluorescence imaging. Dev Growth Differ (2013) 55(4):390-405. doi:10.1111/dgd.12062
64. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol (2003) 171(6):2960-9. doi:10.4049/jimmunol.171.6.2960
65. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol (2008) 181(1):81-91. doi:10.4049/jimmunol.181.1.81
66. Kim CH, Butcher EC, Johnston B. Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol (2002) 23(11):516-9. doi:10.1016/S1471-4906(02)02323-2
67. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol (2005) 3(4):e113. doi:10.1371/journal.pbio.0030113
68. Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med (2011) 17(11):1381-90. doi:10.1038/nm.2514
69. Thomas SY, Scanlon ST, Griewank KG, Constantinides MG, Savage AK, Barr KA, et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med (2011) 208(6):1179-88. doi:10.1084/jem.20102630
70. Emoto M, Mittrucker HW, Schmits R, Mak TW, Kaufmann SH. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J Immunol (1999) 162(9):5094-8.
71. Wong CH, Kubes P. Imaging natural killer T cells in action. Immunol Cell Biol (2013) 91(4):304-10. doi:10.1038/icb.2013.6
72. Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue ER. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 94(8):3909-13. doi:10.1073/pnas.94.8.3909
73. Munoz MA, Biro M, Weninger W. T cell migration in intact lymph nodes in vivo. Curr Opin Cell Biol (2014) 30:17-24. doi:10.1016/j.ceb.2014.05.002
74. Velazquez P, Cameron TO, Kinjo Y, Nagarajan N, Kronenberg M, Dustin ML. Activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J Immunol (2008) 180(4):2024-8. doi:10.4049/jimmunol.180.4.2024
75. Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H, et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology (2000) 31(4):907-15. doi:10.1053/he.2000.5850
76. Barral P, Sanchez-Nino MD, van Rooijen N, Cerundolo V, Batista FD. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J (2012) 31(10):2378-90. doi:10.1038/emboj.2012.87
77. Shekhar S, Joyee AG, Gao X, Peng Y, Wang S, Yang J, et al. Invariant natural killer T cells promote T cell immunity by modulating the function of lung dendritic cells during Chlamydia Pneumoniae infection. J Innate Immun (2014) 7(3):260-74. doi:10.1159/000368779
78. Lee WY, Sanz MJ, Wong CHY, Hardy PO, Salman-Dilgimen A, Moriarty TJ, et al. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading lyme Borrelia. Proc Natl Acad Sci U S A (2014) 111(38):13936-41. doi:10.1073/pnas.1404769111
79. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell (2012) 150(6):1235-48. doi:10.1016/j.cell.2012.07.021
80. King IL, Amiel E, Tighe M, Mohrs K, Veerapen N, Besra G, et al. The mechanism of splenic invariant NKT cell activation dictates localization in vivo. J Immunol (2013) 191(2):572-82. doi:10.4049/jimmunol.1300299
81. DeKruyff RH, Yu S, Kim HY, Umetsu DT. Innate immunity in the lung regulates the development of asthma. Immunol Rev (2014) 260(1):235-48. doi:10.1111/imr.12187
82. Scanlon ST, Thomas SY, Ferreira CM, Bai L, Krausz T, Savage PB, et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med (2011) 208(10):2113-24. doi:10.1084/jem.20110522
83. Shimizu K, Sato Y, Shinga J, Watanabe T, Endo T, Asakura M, et al. KLRG+ invariant natural killer T cells are long-lived effectors. Proc Natl Acad Sci U S A (2014) 111(34):12474-9. doi:10.1073/pnas.1406240111
84. Kawahara K, Moll H, Knirel YA, Seydel U, Zahringer U. Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. Eur J Biochem (2000) 267(6):1837-46. doi:10.1046/j.1432-1327.2000.01189.x
85. Dieckmann R, Graeber I, Kaesler I, Szewzyk U, von Dohren H. Rapid screening and dereplication of bacterial isolates from marine sponges of the Sula Ridge by Intact-Cell-MALDI-TOF mass spectrometry (ICM-MS). Appl Microbiol Biotechnol (2005) 67(4):539-48. doi:10.1007/s00253-004-1812-2
86. Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol (2005) 35(6):1692-701. doi:10.1002/eji.200526157
87. Wu D, Xing GW, Poles MA, Horowitz A, Kinjo Y, Sullivan B, et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A (2005) 102(5):1351-6. doi:10.1073/pnas.0408696102
88. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 7(9):978-86. doi:10.1038/ni1380
89. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 12(10):966-74. doi:10.1038/ni.2096
90. Shapiro ED. Lyme disease. N Engl J Med (2014) 370(18):1724-31. doi:10.1056/NEJMcp1314325
91. Biesiada G, Czepiel J, Lesniak MR, Garlicki A, Mach T. Lyme disease: review. Arch Med Sci (2012) 8(6):978-82. doi:10.5114/aoms.2012.30948
92. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol (2009) 27:147-63. doi:10.1146/annurev.immunol.021908.132629
93. Mehr S, Wood N. Streptococcus pneumoniae-a review of carriage, infection, serotype replacement and vaccination. Paediatr Respir Rev (2012) 13(4):258-64. doi:10.1016/j.prrv.2011.12.001
94. Deng X, Church D, Vanderkooi OG, Low DE, Pillai DR. Streptococcus pneumoniae infection: a Canadian perspective. Expert Rev Anti Infect Ther (2013) 11(8):781-91. doi:10.1586/14787210.2013.814831
95. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol (2008) 6(4):288-301. doi:10.1038/nrmicro1871
96. Kawakami K, Yamamoto N, Kinjo Y, Miyagi K, Nakasone C, Uezu K, et al. Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol (2003) 33(12):3322-30. doi:10.1002/eji.200324254
97. Chang YJ, Kim HY, Albacker LA, Lee HH, Baumgarth N, Akira S, et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest (2011) 121(1):57-69. doi:10.1172/JCI44845
98. Amprey JL, Im JS, Turco SJ, Murray HW, Illarionov PA, Besra GS, et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med (2004) 200(7):895-904. doi:10.1084/jem.20040704
99. Lotter H, Gonzalez-Roldan N, Lindner B, Winau F, Isibasi A, Moreno-Lafont M, et al. Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess. PLoS Pathog (2009) 5(5):e1000434. doi:10.1371/journal.ppat.1000434
100. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 10(12):826-37. doi:10.1038/nri2873
101. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol (2008) 8(4):279-89. doi:10.1038/nri2215
102. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol (2010) 28:321-42. doi:10.1146/annurev-immunol-030409-101311
103. Gapin L. iNKT cell autoreactivity: what is 'self' and how is it recognized? Nat Rev Immunol (2010) 10(4):272-7. doi:10.1038/nri2743
104. Ilan Y. Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells? Clin Exp Immunol (2009) 158(3):300-7. doi:10.1111/j.1365-2249.2009.04030.x
105. Godfrey DI, Pellicci DG, Rossjohn J. Beta-testing NKT cell self-reactivity. Nat Immunol (2011) 12(12):1135-7. doi:10.1038/ni.2162
106. Kain L, Webb B, Anderson BL, Deng S, Holt M, Costanzo A, et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity (2014) 41(4):543-54. doi:10.1016/j.immuni.2014.08.017
107. Oshima T, Sonoda KH, Nakao S, Hijioka K, Taniguchi M, Ishibashi T. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation. Invest Ophthalmol Vis Sci (2008) 49(1):105-12. doi:10.1167/iovs.07-0284
108. Faunce DE, Gamelli RL, Choudhry MA, Kovacs EJ. A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J Leukoc Biol (2003) 73(6):747-55. doi:10.1189/jlb.1102540
109. Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke (2007) 38(3):1097-103. doi:10.1161/01.STR.0000258346.68966.9d
110. Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol (2011) 11:110. doi:10.1186/1471-2377-11-110